Axcelis Technologies Inc: Form 10-Q for the period ended Sep 30, 2011
Filed with the SEC on Nov 4, 2011 and accepted by EDGAR at Nov 4, 2011, 12:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-07-01 to 2011-09-30 | $72.5m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2011-01-01 to 2011-09-30 | $259.0m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-07-01 to 2011-09-30 | $45.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2011-01-01 to 2011-09-30 | $166.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2011-07-01 to 2011-09-30 | $26.9m | us-gaap:GrossProfit |
| Gross profit | 9 months2011-01-01 to 2011-09-30 | $92.1m | us-gaap:GrossProfit |
| Research and development | 3 months2011-07-01 to 2011-09-30 | $11.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2011-01-01 to 2011-09-30 | $35.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2011-07-01 to 2011-09-30 | −$189.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-01-01 to 2011-09-30 | $8.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2011-07-01 to 2011-09-30 | $230.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2011-01-01 to 2011-09-30 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-07-01 to 2011-09-30 | $1.2m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months2011-01-01 to 2011-09-30 | $7.2m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months2011-07-01 to 2011-09-30 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2011-01-01 to 2011-09-30 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-07-01 to 2011-09-30 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2011-01-01 to 2011-09-30 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2011-07-01 to 2011-09-30 | 108,192,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2011-01-01 to 2011-09-30 | 109,452,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2011-01-01 to 2011-09-30 | $852.0k | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2011-01-01 to 2011-09-30 | $1.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2011-09-30 | $44.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-09-30 | $215.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-09-30 | $272.7m | us-gaap:Assets |
| Current liabilities | At period end2011-09-30 | $49.6m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2011-09-30 | $215.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-11-061003. Last ingested by Listed: Nov 13, 2026, 17:24 ET. Listed shows no prices and gives no investment advice.